Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
O'Byrne Jason
EVP & Chief Financial Officer at Vir Biotechnology. Filing since 17 Nov 2025.
CIK 0001871145
Company
Date
Role
Action
Shares
Amount
Of holding
VIR
Vir Biotechnology, Inc.
24 Feb 2026
EVP & Chief Financial Officer
Sold on a plan
1,634
$15.58K
1.0%
VIR
Vir Biotechnology, Inc.
23 Feb 2026
EVP & Chief Financial Officer
Sold on a plan
2,089
$15.57K
1.3%
VIR
Vir Biotechnology, Inc.
17 Nov 2025
EVP & Chief Financial Officer
Sold on a plan
6,799
$37.78K
5.8%
3 decisions on file.
